Legal & General Group
TMDX icon

Legal & General Group’s Transmedics TMDX Stock Holding History

Legal & General Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.83M Sell
78,753
-7,115
-8% -$928K ﹤0.01% 1252
2025
Q4 		$10.4M Sell
85,868
-2,292
-3% -$288K ﹤0.01% 1146
2025
Q3 		$9.89M Sell
88,160
-4,364
-5% -$511K ﹤0.01% 1225
2025
Q2 		$12.4M Sell
92,524
-149
-0.2% -$16.4K ﹤0.01% 1083
2025
Q1 		$6.24M Sell
92,673
-2,866
-3% -$197K ﹤0.01% 1410
2024
Q4 		$5.96M Buy
95,539
+5,582
+6% +$520K ﹤0.01% 1490
2024
Q3 		$14.1M Buy
89,957
+54,645
+155% +$8.42M ﹤0.01% 993
2024
Q2 		$5.32M Buy
35,312
+2,276
+7% +$273K ﹤0.01% 1493
2024
Q1 		$2.44M Buy
33,036
+134
+0.4% +$11K ﹤0.01% 1847
2023
Q4 		$2.6M Buy
32,902
+2,115
+7% +$128K ﹤0.01% 1818
2023
Q3 		$1.69M Buy
30,787
+970
+3% +$69.8K ﹤0.01% 1973
2023
Q2 		$2.5M Buy
29,817
+15,076
+102% +$1.15M ﹤0.01% 1819
2023
Q1 		$1.12M Buy
14,741
+1,705
+13% +$118K ﹤0.01% 2112
2022
Q4 		$805K Buy
13,036
+70
+0.5% +$3.72K ﹤0.01% 2212
2022
Q3 		$542K Sell
12,966
-536
-4% -$23.3K ﹤0.01% 2325
2022
Q2 		$425K Buy
13,502
+631
+5% +$16.8K ﹤0.01% 2382
2022
Q1 		$347K Hold
12,871
– – ﹤0.01% 2491
2021
Q4 		$247K Buy
12,871
+44
+0.3% +$1.1K ﹤0.01% 2628
2021
Q3 		$424K Buy
12,827
+9,032
+238% +$276K ﹤0.01% 2467
2021
Q2 		$126K Buy
3,795
+1,055
+39% +$29.2K ﹤0.01% 2667
2021
Q1 		$114K Sell
2,740
-242
-8% -$7.45K ﹤0.01% 2585
2020
Q4 		$59K Hold
2,982
– – ﹤0.01% 2756
2020
Q3 		$41K Sell
2,982
-277
-8% -$4.75K ﹤0.01% 2759
2020
Q2 		$58K Buy
3,259
+913
+39% +$14.3K ﹤0.01% 2687
2020
Q1 		$28K Sell
2,346
-512
-18% -$8.58K ﹤0.01% 2790
2019
Q4 		$54K Buy
2,858
+1,765
+161% +$32.4K ﹤0.01% 2789
2019
Q3 		$26K Hold
1,093
– – ﹤0.01% 3038
2019
Q2 		$32K Buy
+1,093
New +$29.8K ﹤0.01% 2984

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's TMDX Position: Q1 2026 in Review

Legal & General Group reduced its Transmedics (TMDX) stake by 8.3% in Q1 2026, selling an estimated $928K and leaving 78,753 shares worth $7.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Legal & General Group first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $14.1M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Legal & General Group held 78,753 shares of Transmedics worth $7.83M as of Q1 2026.
  • Legal & General Group sold 7,115 Transmedics shares in Q1 2026, an estimated $928K.
  • Transmedics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1252 holding.
  • Legal & General Group first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • Legal & General Group's Transmedics position peaked at $14.1M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.